Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:TEL
NYSE:TELElectronic

TE Connectivity (TEL) Margin Breakout To 15.6% Puts Bullish Narrative Under Scrutiny

TE Connectivity (TEL) has just posted Q2 2026 results with revenue of US$4.7 billion and basic EPS of US$2.92, alongside trailing twelve month revenue of US$18.7 billion and EPS of US$9.87 that follow a reported 108.3% earnings gain over the past year. Over recent quarters, revenue has moved from US$4.1 billion in Q2 2025 to US$4.7 billion in Q2 2026, while quarterly basic EPS stepped from US$0.04 to US$2.92. This sets up a picture where stronger profitability and a higher net margin are...
NasdaqGS:MYRG
NasdaqGS:MYRGConstruction

Is It Too Late To Consider Buying MYR Group (MYRG) After Its 1-Year Share Price Surge?

Wondering whether MYR Group's share price still offers value at current levels or whether you might be late to the story starts with understanding how the market is currently pricing the business. The stock last closed at US$333.04, with returns of 3.9% over 7 days, 21.4% over 30 days, 46.9% year to date, 185.8% over 1 year, 182.4% over 3 years, and 362.1% over 5 years. This gives important context before you compare that price with any estimate of fair value. Recent attention on MYR Group...
NasdaqGS:BRKR
NasdaqGS:BRKRLife Sciences

Bruker Bets On Diagnostics And NMR To Reinforce Growth Story

Bruker (NasdaqGS:BRKR) announced new products in microbiology, infection diagnostics and NMR technology, alongside the European launch of a fully automated molecular diagnostics system. The company is expanding its MALDI Biotyper and MyGenius PRO platforms and progressing the integration of Molzym and its pathogen diagnostics portfolio. For investors tracking Bruker, the news arrives with the shares at $39.67. The stock shows mixed performance, with a 13.8% return over the past 30 days and...
NasdaqGS:CAPR
NasdaqGS:CAPRBiotechs

How Investors May Respond To Capricor Therapeutics (CAPR) HOPE-3 Data and Pending FDA Decision

Capricor Therapeutics recently presented Phase 3 HOPE-3 data for its Duchenne muscular dystrophy therapy Deramiocel at the 2026 American Academy of Neurology meeting, highlighting preserved function and slower disease progression, including real-world self-feeding outcomes captured via the Duchenne Video Assessment. The company emphasized that these clinical results, combined with Deramiocel’s multiple regulatory designations and an ongoing FDA Biologics License Application review with an...
NYSE:XPO
NYSE:XPOTransportation

Is XPO’s (XPO) LTL Service Gains Quietly Redrawing Its Competitive Positioning Narrative?

In the first quarter of 2026, Carillon Tower Advisers highlighted XPO, Inc.’s strong less‑than‑truckload performance and improved service levels, even as freight conditions remained difficult. This recognition underscored how XPO’s operational execution is helping narrow its service and pricing gap with a leading peer, which may influence how investors view its longer-term prospects. Next, we’ll examine how this operational improvement spotlight fits with XPO’s existing investment narrative...
NasdaqGS:CME
NasdaqGS:CMECapital Markets

CME Group (CME) Margin Strength In Q1 2026 Tests Cautious Growth Narratives

CME Group (CME) opened 2026 with Q1 revenue of US$1.9b and basic EPS of US$3.25, setting the tone for another data rich update for shareholders. The company has seen quarterly revenue move from US$1.6b in Q1 2025 to US$1.9b in Q1 2026, while basic EPS has shifted from US$2.63 to US$3.25 over the same period, against a backdrop of trailing 12 month earnings growth of 18.5%. For investors, the combination of higher trailing net margins and these headline figures puts the focus firmly on how...
NYSE:FBP
NYSE:FBPBanks

First BanCorp (FBP) Margins At 38.2% Challenge Cautious Earnings Narratives After Q1 2026

First BanCorp (FBP) opened 2026 with Q1 revenue of US$241.4 million and basic EPS of US$0.57, alongside trailing 12 month revenue of US$932.9 million and EPS of US$2.26 that frame the latest quarterly print in a broader earnings run rate. Over the past year, the bank has seen revenue move from US$876.8 million to US$932.9 million on a trailing basis while EPS shifted from US$1.82 to US$2.26, giving a clearer read on how the top and bottom lines have been tracking into this quarter. With a...
NYSE:AERO
NYSE:AEROAirlines

Grupo Aeroméxico (NYSE:AERO) Margin Compression In Q1 2026 Tests Premium-Growth Narrative

Grupo Aeroméxico. de (NYSE:AERO) has opened 2026 with Q1 revenue of US$1.3 billion and basic EPS of US$0.08, alongside trailing twelve month revenue of US$5.5 billion and EPS of US$2.34 that frame the latest quarter in a broader earnings context. The company has seen quarterly revenue move from US$1.18 billion in Q1 2025 to US$1.44 billion in Q4 2025 before landing at US$1.34 billion in Q1 2026, while basic EPS has ranged from US$0.16 to US$0.97 over the past year. This sets up a results...
NasdaqGS:LYFT
NasdaqGS:LYFTTransportation

Is It Time To Reassess Lyft (LYFT) After Recent Share Price Swings?

If you are wondering whether Lyft at around US$14.44 offers fair value or a margin of safety, this article walks through what the current price might be indicating. The stock has had mixed returns, with a 1.5% decline over the last 7 days, an 8.2% gain over the last 30 days, a 27.0% decline year to date, and a 26.2% return over the past year. This can indicate that the market is still adjusting its view on risk and potential. Recent headlines around Lyft have focused on its position in the...
NYSE:RH
NYSE:RHSpecialty Retail

Is RH’s New Synchrony Card Deepening Customer Loyalty Or Shifting Its Risk Profile (RH)?

In April 2026, Synchrony announced the launch of the RH Credit Card, a financing solution for RH customers that offers promotional financing across RH Galleries, Outlets, and RH.com, fully integrated into the RH Members Program with streamlined digital prequalification and application. An interesting angle is RH’s access to Synchrony’s PRISM decisioning system, which uses thousands of data points to support more tailored and responsible credit offerings for its clientele. We’ll now examine...
BME:GRF
BME:GRFBiotechs

Grifols Early Parkinson’s Signal Puts Plasma Know How To New Use

Grifols (BME:GRF) reported proof of concept data from its Chronos-PD program. The company found molecular changes linked to Parkinson’s disease in blood plasma. These changes were detected up to 12 years before clinical diagnosis. Grifols, best known for its plasma derived therapies and diagnostic products, is extending that expertise into neurology with Chronos-PD. The early Parkinson’s signal in plasma connects directly to the company’s existing strengths in blood based testing, an area...
NYSE:CRK
NYSE:CRKOil and Gas

Is Comstock Resources (CRK) Now Attractively Priced After Recent Share Price Pullback?

If you are wondering whether Comstock Resources at US$17.44 is genuinely good value or just looks cheap on the surface, the key is to understand how its current price compares with different valuation measures. The stock has recently shown mixed returns, with a 7.2% gain over the last week, a 17.7% decline over the last month, and returns of 26.0% decline year to date and 5.6% decline over the last year, set against a 69.7% return over three years and a 238.2% return over five years. Recent...
TSXV:CEI
TSXV:CEIOil and Gas

Coelacanth Energy Q4 Loss Of C$2.2 Million Tests Bullish Valuation Narratives

Coelacanth Energy (TSXV:CEI) closed out FY 2025 with Q4 revenue of C$10.1 million and a basic EPS loss of C$0.0036, alongside trailing twelve month revenue of C$25.2 million and a TTM basic EPS loss of C$0.02. Over the last six reported quarters, revenue has ranged from C$1.98 million in Q3 2024 to C$10.1 million in Q4 2025, while quarterly basic EPS has stayed in loss-making territory between C$0.0033 and C$0.0068 per share. For investors, the latest results keep the focus on whether CEI can...
NYSE:WAB
NYSE:WABMachinery

Wabtec (WAB) Q1 EPS Growth Tests Bullish Long Term Earnings Narrative

Westinghouse Air Brake Technologies (WAB) opened 2026 with Q1 revenue of US$2.95b and basic EPS of US$2.13, setting the tone for how the year is starting to shape up after a period of steady earnings expansion. The company has seen revenue move from US$2.61b in Q1 2025 to US$2.95b in Q1 2026, while basic EPS over that span ranged from US$1.88 in Q1 2025 to US$2.13 in the latest quarter. Trailing twelve month EPS reached US$7.08 as net income for that period came in at US$1.21b. With earnings...
NYSE:GEV
NYSE:GEVElectrical

GE Vernova (GEV) Net Margin Surge Reinforces Bullish Profitability Narratives

GE Vernova (GEV) has opened 2026 with Q1 total revenue of US$9.3 billion and basic EPS of US$17.64 on net income of US$4.7 billion, setting a clear marker for its latest earnings season update. The company has seen quarterly revenue move from US$8.0 billion in Q1 2025 to US$9.3 billion in Q1 2026, while basic EPS stepped up from US$0.92 to US$17.64 over the same period, alongside trailing 12 month EPS of US$34.66 and net income of US$9.4 billion. With revenue growth forecasts above the wider...
NYSE:PLOW
NYSE:PLOWMachinery

A Look At Douglas Dynamics (PLOW) Valuation After Recent Share Price Momentum

Douglas Dynamics (PLOW) is back on investor radars after recent share price moves, with the stock showing gains over the past month and past 3 months that stand out compared with its longer term record. See our latest analysis for Douglas Dynamics. The recent share price return of 10.5% over 30 days and 21.6% over 90 days, alongside a 38.6% year to date share price return and 101.1% 1 year total shareholder return, points to strong momentum building around Douglas Dynamics at a last close of...
TSX:CSU
TSX:CSUSoftware

Did Perceived Undervaluation and New Leadership Just Shift Constellation Software's (TSX:CSU) Investment Narrative?

In recent weeks, Constellation Software has been highlighted as trading below estimated future cash flow value while facing high debt levels, thinner profit margins, and leadership changes that could influence its Permanent Engaged Minority Shareholder strategy. This mix of perceived undervaluation, strong analyst earnings growth forecasts and a refreshed executive team is reshaping how investors weigh the company’s risks and long-term potential. We’ll now examine how the perceived...
NasdaqGS:HQY
NasdaqGS:HQYHealthcare

Is HealthEquity (HQY) Pricing Reflect Its DCF Upside After Recent Share Price Pullback

Wondering if HealthEquity at around US$82.88 is priced for its future potential or already reflects the story you are buying into today? This article focuses squarely on what you are getting for the price you pay. The stock has delivered a 54.0% return over 3 years, while the 1 year return sits at a 3.7% decline and the year to date move is a 9.0% decline, which may have shifted how investors are thinking about both upside and risk. Recent coverage has focused on HealthEquity's role in US...
NasdaqCM:LIND
NasdaqCM:LINDHospitality

A Look At Lindblad Expeditions Holdings (LIND) Valuation After Recent Share Price Pullback

Market context for Lindblad Expeditions Holdings (LIND) Lindblad Expeditions Holdings (LIND) has drawn investor attention after recent share price moves, with the stock showing mixed short term performance while posting stronger total returns over the past year and past 3 months. The company, which runs marine expedition adventures and land based travel experiences, now carries a market value of about US$1.22b and last closed at US$18.33. This has prompted closer scrutiny of its current...
NasdaqGS:HAFC
NasdaqGS:HAFCBanks

Hanmi Financial (HAFC) Net Interest Margin Strengthens Narrative On Profit Quality In Q1 2026

Hanmi Financial (HAFC) kicked off Q1 2026 with total revenue of US$68.9 million and basic EPS of US$0.76, set against trailing 12 month revenue of US$264.5 million and EPS of US$2.70, alongside earnings growth of 25.3% over the last year. Over recent periods, revenue has moved from US$59.9 million in Q4 2024 to US$60.1 million in Q1 2025, then to US$57.6 million in Q2 2025, US$68.8 million in Q3 2025, US$69.2 million in Q4 2025, and now US$68.9 million in Q1 2026. EPS has tracked from US$0.59...
TSX:VZLA
TSX:VZLAMetals and Mining

Security Concerns Put Vizsla Silver’s Mexican Project And Valuation In Focus

Security incidents at Vizsla Silver's Mexican project site have included fatal abductions of employees. These events have drawn increased attention from high profile commentators and the wider investment community. The situation raises questions about operational risk and future activity at the project. For investors watching Vizsla Silver (TSX:VZLA), the security situation now sits alongside the share price at CA$4.72 and a mixed return profile. The stock shows a 53.2% gain over the past...
NYSE:YUMC
NYSE:YUMCHospitality

A Look At Yum China (YUMC) Valuation After Recent Share Price Weakness

Assessing recent performance and business scale Yum China Holdings (YUMC) has drawn attention after a monthly return of about a 7% decline, alongside a past 3-month move of roughly a 2% decline. This performance has prompted a closer look at its fundamentals. The company operates restaurant brands such as KFC, Pizza Hut, Taco Bell, Lavazza, Little Sheep, and Huang Ji Huang across the People’s Republic of China. It reported revenue of US$11.8b and net income of US$929.0m. See our latest...